119 related articles for article (PubMed ID: 1356011)
1. Novel antitumor peptide hormones and their effect on signal transduction.
Kéri G; Balogh A; Horváth A; Mezö I; Vadász Z; Bökönyi G; Bajor T; Vántus T; Teplán I; Horváth J
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):105-10. PubMed ID: 1356011
[TBL] [Abstract][Full Text] [Related]
2. Peptides and antitumor activity. Development and investigation of some peptides with antitumor activity.
Teplán I
Acta Biol Hung; 2000; 51(1):1-29. PubMed ID: 10866357
[TBL] [Abstract][Full Text] [Related]
3. Gonadotropin-releasing hormone analogues inhibit cell proliferation and activate signal transduction pathways in MDA-MB-231 human breast cancer cell line.
Kéri G; Balogh A; Szöke B; Teplán I; Csuka O
Tumour Biol; 1991; 12(2):61-7. PubMed ID: 1902971
[TBL] [Abstract][Full Text] [Related]
4. Novel somatostatin analogs with tyrosine kinase inhibitory and antitumor activity.
Kéri G; Mezö I; Horváth A; Vadász Z; Balogh A; Idei M; Vántus T; Teplán I; Mák M; Horváth J
Biochem Biophys Res Commun; 1993 Mar; 191(2):681-7. PubMed ID: 8096383
[TBL] [Abstract][Full Text] [Related]
5. Antitumour activity of folligen, a novel gonadotropin-releasing hormone analogue against DMBA-induced tumours in the rat.
Nicholson RI; Kéri G
Tumour Biol; 1992; 13(1-2):44-50. PubMed ID: 1534181
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of LHRH and somatostatin analogs on human breast cancer.
Brower ST; Schally AV; Redding TW; Hollander VP
J Surg Res; 1992 Jan; 52(1):6-14. PubMed ID: 1347798
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship studies of novel somatostatin analogs with antitumor activity.
Kéri G; Mezô I; Vadász Z; Horváth A; Idei M; Vántus T; Balogh A; Bökönyi G; Bajor T; Teplán I
Pept Res; 1993; 6(5):281-8. PubMed ID: 7903057
[TBL] [Abstract][Full Text] [Related]
8. Effect of gonadotropin-releasing hormone analogs and their conjugates on gonadotropin-releasing hormone receptor--positive human cancer cell lines.
Pályi I; Vincze B; Kálnay A; Turi G; Mezõ I; Teplán I; Seprõdi J; Pató J; Móra M
Cancer Detect Prev; 1996; 20(2):146-52. PubMed ID: 8706040
[TBL] [Abstract][Full Text] [Related]
9. The tumor-selective somatostatin analog, TT2-32 induces a biphasic activation of phosphotyrosine phosphatase activity in human colon tumor cell line, SW620.
Vántus T; Csermely P; Teplán I; Kéri G
Tumour Biol; 1995; 16(4):261-7. PubMed ID: 7604207
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitro.
Florio T; Thellung S; Corsaro A; Bocca L; Arena S; Pattarozzi A; Villa V; Massa A; Diana F; Schettini D; Barbieri F; Ravetti JL; Spaziante R; Giusti M; Schettini G
Clin Endocrinol (Oxf); 2003 Jul; 59(1):115-28. PubMed ID: 12807513
[TBL] [Abstract][Full Text] [Related]
11. The antitumor activity of the somatostatin structural derivative (TT-232) on different human tumor xenografts.
Tejeda M; Gaal D; Barna K; Csuka O; Kéri G
Anticancer Res; 2003; 23(5A):4061-6. PubMed ID: 14666719
[TBL] [Abstract][Full Text] [Related]
12. A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity.
Kéri G; Erchegyi J; Horváth A; Mezõ I; Idei M; Vántus T; Balogh A; Vadász Z; Bökönyi G; Seprõdi J; Teplán I; Csuka O; Tejeda M; Gaál D; Szegedi Z; Szende B; Roze C; Kalthoff H; Ullrich A
Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12513-8. PubMed ID: 8901613
[TBL] [Abstract][Full Text] [Related]
13. Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates in various tumors.
Lee MT; Liebow C; Kamer AR; Schally AV
Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1656-60. PubMed ID: 1672042
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative and GH-inhibitory activity of chimeric peptides consisting of GHRP-6 and somatostatin.
Dasgupta P; Singh AT; Mukherjee R
Biochem Biophys Res Commun; 1999 Jun; 259(2):379-84. PubMed ID: 10362518
[TBL] [Abstract][Full Text] [Related]
15. Effects of new somatostatin analogs on the cell proliferation of colonic crypts and colonic cancers in rats.
Zerek-Mełeń G; Pawlikowski M; Winczyk K; Lachowicz-Ochedalska A; Legowska A; Kwaśny H; Przybylski J; Szadowska A
Neuropeptides; 1993 Jul; 25(1):57-60. PubMed ID: 8105412
[TBL] [Abstract][Full Text] [Related]
16. New endocrine approaches to breast cancer.
Howell A; Dodwell DJ; Anderson H
Baillieres Clin Endocrinol Metab; 1990 Mar; 4(1):67-84. PubMed ID: 1975167
[No Abstract] [Full Text] [Related]
17. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
[TBL] [Abstract][Full Text] [Related]
18. Novel heptapeptide somatostatin analog displays anti-tumor activity independent of effects on growth hormone secretion.
Murphy WA; Taylor JE; Moreau JP; Coy DH
Pept Res; 1989; 2(1):128-32. PubMed ID: 2577697
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
Schally AV; Redding TW
Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7275-9. PubMed ID: 2890164
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effects of somatostatin mediated by the stimulation of tyrosine phosphatase.
Liebow C; Lee MT; Schally A
Metabolism; 1990 Sep; 39(9 Suppl 2):163-6. PubMed ID: 1976210
[No Abstract] [Full Text] [Related]
[Next] [New Search]
